Sio Gene Therapies Inc

NASDAQ:SIOX   10:07:22 AM EDT
0.31
-0.01 (-2.52%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Sio Gene Therapies Inc Stock, NASDAQ:SIOX

1501 Broadway, 12th floor, New York, New York 10036
United States of America
Phone: +1.646.677.6770
Number of Employees: 12

Description

Sio Gene Therapies, Inc. is a clinical-stage biopharmaceutical company, which engages in the acquisition, development, and commercialization of gene therapies for neurological diseases. Its product pipeline focuses on Parkinson's Disease, GM1 gangliosidosis, and GM2 gangliosidosis, such as Tay-Sachs disease and Sandhoff disease. The company was founded on October 31, 2014 and is headquartered in New York, NY.